Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL5226146 | 0.94 | ALDH1A1 (0.54) | ALDH1A1TDP1LMNA | |
| SCHEMBL28141452 | 0.87 | ALDH1A1 (0.52) | ALDH1A1TDP1LMNA | |
| SCHEMBL1830406 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TDP1 | |
| SCHEMBL8563124 | 0.83 | ALDH1A1 (0.65) | ALDH1A1TDP1 | |
| Sorbitol SCHEMBL1830742 | 0.82 | TDP1 (0.56) | ALDH1A1TDP1LMNA | |
| Isopropyl Alcohol SCHEMBL18894306 | 0.80 | — | — | |
| Glycerin SCHEMBL10788232 | 0.80 | ALDH1A1 (0.47) | ALDH1A1TDP1LMNATHRB | |
| Ethylene Glycol SCHEMBL8467093 | 0.79 | — | — | |
| Hydrogen Peroxide SCHEMBL28159702 | 0.79 | — | — | |
| SCHEMBL118159 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5077167-A | Encapsulated toner compositions | XEROX CORPORATION (US) | 1991-12-31 | — | — | US | claimed |
| US-20260117190-A1 | METHODS AND SYSTEMS FOR CONVERTING PRECURSOR CELLS INTO INTESTINAL TISSUES THROUGH DIRECTED DIFFERENTIATION | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260115694-A1 | Single-atom Nanozymes, Preparation and Applications thereof | UNIV CITY HONG KONG (HK) | 2026-04-30 | — | — | US | disclosed |
| US-12613238-B2 | Diagnostic and prognostic utility of exosomes in immunotherapy | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-04-28 | — | — | US | disclosed |
| US-20260033484-A1 | CROSS-CIRCULATION PLATFORM FOR RECOVERY, REGENERATION, AND MAINTENANCE OF EXTRACORPOREAL ORGANS | UNIV COLUMBIA (US) | 2026-02-05 | — | — | US | disclosed |
| EP-4685158-A1 | FIBRILLARY APOLIPOPROTEIN E (APOE) FOR USE IN A METHOD OF TREATMENT AND/OR PREVENTION OF A NEURODEGENERATIVE DISEASE | Technische Universität München (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-20250388761-A1 | HYBRID ORGANIC-INORGANIC TWO-DIMENSIONAL METAL CARBIDE MXENES | UNIV CHICAGO (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250352562-A1 | PREVENTION OF SYMPATHETIC DENERVATION OF THE PINEAL GLAND IN CARDIAC DISEASE | UNIV MUENCHEN TECH (DE) | 2025-11-20 | — | — | US | disclosed |
| US-12446572-B2 | Cross-circulation platform for recovery, regeneration, and maintenance of extracorporeal organs | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-10-21 | — | — | US | disclosed |
| WO-2025217271-A1 | CRYO-EM STRUCTURE OF THE BRINE SHRIMP ATP SYNTHASE AND AN INACTIVATION MECHANISM OF ATP SYNTHASE LEAK CHANNEL FOR USE IN THERAPEUTIC APPROACHES | THE PENN STATE RESEARCH FOUNDATION (US) | 2025-10-16 | — | — | WO | disclosed |
| US-4436909-A | HAIR COSMETICS | L'OREAL (FR) | 1984-03-13 | — | — | US | disclosed |
| US-4397985-A | GAMMA-GLYCIDOXYPROPYLTRIMETHOXYSILANE | ALLIED CORPORATION (US) | 1983-08-09 | — | — | US | disclosed |
| US-4389456-A | YARNS, LUBRICANTS, OXIDATION RESISTANCE | ALLIED CORPORATION (US) | 1983-06-21 | — | — | US | disclosed |
| EP-0079443-A2 | Stabilized finish composition | ALLIED CORPORATION (US) | 1983-05-25 | — | — | EP | disclosed |
| US-4220602-A | FOR HAIR COSMETICS | L'OREAL (FR) | 1980-09-02 | — | — | US | disclosed |
| US-4133783-A | Thermosetting cellulose ester powder coating composition | EASTMAN KODAK COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4096332-A | POLYHYDROXYLATED TERTIARY AMINES OR QUATERNARY AMMONIUM SALTS THEREOF | L'OREAL (FR) | 1978-06-20 | — | — | US | disclosed |
| US-4009255-A | POLYHYDROXYLATED TERTIARY AMINES | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-02-22 | — | — | US | disclosed |
| US-4001141-A | POLYETHERS | SOCIETE ANONYME DIT: L'OREAL (FR) | 1977-01-04 | — | — | US | disclosed |
| US-3954882-A | Non-ionic surface-active agents derived from fatty chain diols | L'OREAL (FR) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12613238-B2 | Diagnostic and prognostic utility of exosomes in immunotherapy | CD274, ICOS, PDCD1 | ALDH1A1 2974/4885TDP1 2962/4885LMNA 4712/4885 |
| US-20260033484-A1 | CROSS-CIRCULATION PLATFORM FOR RECOVERY, REGENERATION, AND MAINTENANCE OF EXTRACORPOREAL ORGANS | VEGFA, PROX1, CFTR | ALDH1A1 3201/4885TDP1 3577/4885LMNA 4324/4885 |
| US-20260117190-A1 | METHODS AND SYSTEMS FOR CONVERTING PRECURSOR CELLS INTO INTESTINAL TISSUES THROUGH DIRECTED DIFFERENTIATION | ALPG, NOTCH3, PAX3 | ALDH1A1 4225/4885TDP1 4606/4885LMNA 2144/4885 |
| US-20260115694-A1 | Single-atom Nanozymes, Preparation and Applications thereof | CA7, CA2, CA6 | ALDH1A1 3086/4885TDP1 3992/4885LMNA 2458/4885 |
| US-20250388761-A1 | HYBRID ORGANIC-INORGANIC TWO-DIMENSIONAL METAL CARBIDE MXENES | AXIN2, H1-2, NXF1 | ALDH1A1 921/4885TDP1 2454/4885LMNA 1454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.